Anthrazykline in der Therapie des Ovarialkarzinoms – Vergangenheit, Gegenwart und Zukunft

Publisher： Karger

E-ISSN： 2296-5262|23|2|46-52

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.23, Iss.2, 2000-05, pp. : 46-52

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standards in der Therapie des Ovarialkarzinoms

By Pfisterer J.   du Bois A.  

Der Pathologe, Vol. 28, Iss. 3, 2007-05 ,pp. : 222-228

Springer Publishing Company

Access to resources Recommend Favorite

Anthrazykline in der adjuvanten Therapie des Mammakarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 7-11

Karger

Access to resources Recommend Favorite

Caelyx® in der Therapie des fortgeschrittenen Ovarialkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 40-45

Karger

Access to resources Recommend Favorite

Therapie bei Progression und Rezidiv des Ovarialkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 35-39

Karger

Access to resources Recommend Favorite

Second-line-Therapie des Ovarialkarzinoms

By  

Oncology Research and Treatment, Vol. 23, Iss. 6, 2001-01 ,pp. : 593-596

Karger

Access to resources Recommend Favorite